Zdrowie i gospodarka · 25/02/2026
FDA Announces Public Comment Period for Biological Product Deviation Reporting
The FDA is seeking public comment on proposed information collection requirements for reporting biological product deviations and human cells, tissues, and cellular and tissue-based product deviations in manufacturing, as mandated by the Paperwork Reduction Act of 1995.